Bonalive Biomaterials
Nicolas Munoz has extensive experience in the pharmaceutical and biomaterials industries, currently serving on the Board of Directors for Bonalive Biomaterials and Avalon Pharmaceutical LATAM. Additionally, Nicolas is the Founder and CEO of BlueGreen BioPharma and has held roles in business development at Unistraw and Avalon Pharmaceutical S.A. Previous positions include Product Development Manager at Avalon Pharmaceutical S.A. Nicolas holds a Bachelor of International Trade from Donghua University, a Bachelor of Business Administration from The Hong Kong University of Science and Technology, and a Chinese Language Certificate from Fudan University.
This person is not in any teams
This person is not in any offices
Bonalive Biomaterials
As the world seeks answers to the growing threat of antibiotic resistance, Bonalive represents a new standard in patient care. Evolving at the intersection of technology and human biology, our Smart Healing™ technologies reduce antibiotic treatments and enable a better quality of life for patients. Smart Healing™ encompasses our commitment to our customers. It defines everything we do, in providing patients and surgeons well-proven and safe bone regenerative products in orthopedics, trauma, spine, septic bone and ear surgery. It's time to heal smarter. #SmartHealing For indications, contraindications, warnings and precautions related to Bonalive® products refer to the IFU within the product package. This site is not intended for US customers.